DS
UTHR icon

DRW Securities’s United Therapeutics UTHR Stock Holding History

DRW Securities’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-8,000
Closed -$1.08M – 105
2017
Q1 		$1.08M Buy
+8,000
New +$1.21M 0.19% 24

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

DRW Securities's UTHR Position: Q2 2026 in Review

DRW Securities opened a new position in United Therapeutics (UTHR) in Q2 2026: 373 shares worth $202K. The stake represents ﹤0.01% of the portfolio and ranks #808 among its holdings. This is a return to the name: DRW Securities previously reported a position in UTHR as recently as Q4 2025.

DRW Securities first reported a position in UTHR in Q1 2017 and has held it in 4 quarters since. The position peaked at $812K in Q1 2017. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • DRW Securities held 373 shares of United Therapeutics worth $202K as of Q2 2026.
  • United Therapeutics was a new DRW Securities position in Q2 2026.
  • United Therapeutics made up ﹤0.01% of DRW Securities's portfolio in Q2 2026, its #808 holding.
  • DRW Securities first reported a position in United Therapeutics in Q1 2017 and has held it in 4 quarters since.
  • DRW Securities's United Therapeutics position peaked at $812K in Q1 2017.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.